Effect of Rate Of Delivery on Colonic Fermentation of inuliN (EON)

Irritable Bowel Clinical Trial

— EON  

Official title:

Effect of Rate Of Delivery on Colonic Fermentation of inuliN (EON)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05619341
• Other study ID #: FMHS 17-0622
• Status: Completed
• Phase: N/A
• Start date: October 28, 2022
• Est. completion date: April 1, 2023

Study information

• Verified date: April 2024
• Source: University of Nottingham
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To test whether slowing the rate of delivery of inulin with either psyllium or divided dosing of inulin, will reduce colonic gas production as compared to inulin combined with placebo.

To obtain pilot data on link between habitual diet and fermentation of inulin.

Description:

Our challenge is to understand how fibre interacts with whole-gut function to alter colonic fermentation of fermentable oligo-di-mono-saccharides and polyhydric alcohols (FODMAPs). We have previously performed the study entitled the Effect of modified Cellulose On COlonic fermentAtion of inulin (COCOA) in which a modified methylcellulose (food grade product -modified celluloses- which can form gels at body temperature ) was used and showed some reduction, but this was not statistically significant, and much less than with psyllium. We wish to determine whether slowing delivery of inulin will produce a lowering of breath hydrogen equivalent to that seen with psyllium. We also found that the breath hydrogen curve had not shown a consistent fall by 6 hours suggesting that 6 hours was not long enough to accurately define the area under the curve (AUC). We now plan to use breath sampling bags to collect breath samples at home to define the breath hydrogen response over whole 24-hour period post ingestion of test drink. We also hypothesise that the colonic microbiota will influence the fermentation of inulin and will collect stool samples to allow future work to correlate microbiota with fermentation rates as part of a separate Medical Research Council funded study.

Aim Our aim is to test the hypothesis that slowing delivery of inulin will achieve a similar reduction in breath hydrogen production over the 24 hours following ingestion as seen when co-administered with psyllium.

Objective The primary objective is to compare the effect of bolus administration of inulin (co-administrated with psyllium or maltodextrin placebo) with divided dose delivery of inulin over 6 hours on total gas production over 24 hours.

Secondary Objectives Secondary objectives will be 1) to compare breath hydrogen AUC 0-24h with values based on AUC 0-6h that was assessed in the previous study (COCOA) to see how much the shorter period underestimates H2 production; 2) to assess breath methane production AUC 0-24h after consumption of test drinks; and 3) to collect pilot data on habitual dietary FODMAPs intake to assess whether this alters fermentation of inulin.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 17
• Est. completion date: April 1, 2023
• Est. primary completion date: April 1, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• Aged 18 or older.

• Able to give informed consent.

• Scoring =3 (i.e., mild, or less) for symptoms of flatulence, bloating and abdominal pain in previous 2 weeks using a modified Gastrointestinal Symptom Rating Scale (5).

• Agrees to consume the meals provided.

• Agrees to not smoke during the breath hydrogen sampling period

Exclusion Criteria:

• Pregnancy declared by candidate.

• History declared by the candidate of pre-existing gastrointestinal disorder that may affect bowel function.

• Reported history of previous resection of the oesophagus, stomach, or intestine (excluding appendix).

• Intestinal stoma.

• Any medical condition potentially compromising participation in the study e.g., type 1 diabetes mellitus, respiratory disease limiting ability to use breath hydrogen analyser, known intolerance to one of the test substances.

• Will not agree to dietary restrictions required nor consume the standard meals required during the study day.

• Unable to stop drugs known to alter GI motility including mebeverine, opiates, monoamine oxidase inhibitors, phenothiazines, benzodiazepines, calcium channel antagonists for the duration of the study (Selective serotonin reuptake inhibitors, low dose tricyclic antidepressants, antihistamines, and oral contraceptive pill will be recorded in the CRF but will not be an exclusion criteria).

• Participants who are taking antibiotics or probiotics as they might alter gut microbiota.

• Poor understanding of English language.

• Participation in night shift work the week prior to the study day. Night work is defined as working between midnight and 6.00 AM.

• Anyone who in the opinion of the investigator is unlikely to be able to comply with the protocol e.g., cognitive dysfunction, chaotic lifestyle related to substance abuse.

• Having taken part in a research study in the last 3 months involving invasive procedures or an inconvenience allowance.

Related Conditions & MeSH terms

• Irritable Bowel
• Irritable Bowel Syndrome

Intervention

Dietary Supplement:
• psyllium
psyllium 20g
• inulin
long chain fructan

Locations

Country	Name	City	State
United Kingdom	Nottingham Digestive Disease Centre	Nottingham	Nottinghamshire

Sponsors (1)

Lead Sponsor	Collaborator
University of Nottingham

Country where clinical trial is conducted

United Kingdom, 

References & Publications (3)

Dionne J, Ford AC, Yuan Y, Chey WD, Lacy BE, Saito YA, Quigley EMM, Moayyedi P. A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome. Am J Gastroenterol — View Citation

Galvin MA, Kiely M, Harrington KE, Robson PJ, Moore R, Flynn A. The North/South Ireland Food Consumption Survey: the dietary fibre intake of Irish adults. Public Health Nutr. 2001 Oct;4(5A):1061-8. doi: 10.1079/phn2001187. — View Citation

Gunn D, Abbas Z, Harris HC, Major G, Hoad C, Gowland P, Marciani L, Gill SK, Warren FJ, Rossi M, Remes-Troche JM, Whelan K, Spiller RC. Psyllium reduces inulin-induced colonic gas production in IBS: MRI and in vitro fermentation studies. Gut. 2022 May;71( — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Hydrogen production	AUC 0-24h	2 days
Secondary	Methane production	AUC 0-24h	2 days
Secondary	Intake of FOOMDAPS	24 h food diary X 4	4 days